Fludarabine, busulfan, and thiotepa may be a promising conditioning regimen for myelofibrosis patients undergoing allogeneic stem cell transplantation

被引：0

作者：

Shouval, Roni ^{[1
]}

Vega, Yakov ^{[1
]}

Fein, Joshua A. ^{[1
]}

Danylesko, Ivetta ^{[1
]}

Tov, Noga Shem ^{[1
]}

Yerushalmi, Ronit ^{[1
]}

Nagler, Arnon ^{[1
]}

Shimoni, Avichai ^{[1
]}

机构：

[1] Tel Aviv Univ, Chaim Sheba Med Ctr, Hematol & Bone Marrow Transplantat, Ramat Gan, Israel

来源：

BONE MARROW TRANSPLANTATION | 2019年 / 54卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P096

引用

页码：204 / 205

页数：2

共 50 条

[1] Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience
Memoli, Mara
Paviglianiti, Annalisa
Malard, Florent
Battipaglia, Giorgia
Brissot, Eolia
Mediavilla, Clemence
Bianchessi, Antonio
Banet, Anne
Van de Wyngaert, Zoe
Ledraa, Tounes
Belhocine, Ramdane
Sestili, Simona
Lapusan, Simona
Hirsch, Pierre
Favale, Fabrizia
Boussaroque, Agathe
Bonnin, Agnes
Vekhoff, Anne
Legrand, Ollivier
Mohty, Mohamad
Dulery, Remy
LEUKEMIA & LYMPHOMA, 2021, 62 (02) : 419 - 427
[2] THIOTEPA-TREOSULFAN-FLUDARABINE (TTF) AS CONDITIONING REGIMEN IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLOHSCT) FOR MYELOFIBROSIS
Canale, Filippo Antonio
Porto, Gaetana
Verduci, Chiara
Celentano, Maria
Loteta, Barbara
Pugliese, Marta
Naso, Virginia
Moscato, Tiziana
Irrera, Giuseppe
Console, Giuseppe
Ferreri, Anna
Picardi, Alessandra
Martino, Massimo
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 496 - 497
[3] Allogeneic hematopoietic stem cell transplantation with fludarabine, busulfan, and thiotepa conditioning is associated with favorable outcomes in myelofibrosis
Shouval, Roni
Vega, Yakov
Fein, Joshua A.
Danylesko, Ivetta
Tov, Noga Shem
Yerushalmi, Ronit
Sobas, Marta
Czyz, Anna
Nagler, Arnon
Shimoni, Avichai
BONE MARROW TRANSPLANTATION, 2020, 55 (01) : 147 - 156
[4] Allogeneic hematopoietic stem cell transplantation with fludarabine, busulfan, and thiotepa conditioning is associated with favorable outcomes in myelofibrosis
Roni Shouval
Yakov Vega
Joshua A. Fein
Ivetta Danylesko
Noga Shem Tov
Ronit Yerushalmi
Marta Sobas
Anna Czyż
Arnon Nagler
Avichai Shimoni
Bone Marrow Transplantation, 2020, 55 : 147 - 156
[5] Thiotepa-busulfan-fludarbine as Conditioning Regimen for Patients with Myelofibrosis undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience
Memoli, Mara
Paviglianiti, Annalisa
Malard, Florent
Battipaglia, Giorgia
Brissot, Eolia
Mediavilla, Clemence
Bianchessi, Antonio
Banet, Anne
Van de Wyngaert, Zoe
Ledraa, Tounes
Belhocine, Ramdane
Sestili, Simona
Lapusan, Simona
Bonnin, Agnes
Vekhoff, Anne
Legrand, Ollivier
Mohty, Mohamad
Dulery, Remy
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 307 - 308
[6] Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation
Anne Banet
Ali Bazarbachi
Myriam Labopin
Nicolas Stocker
Rémy Duléry
Florent Malard
Zoé Van de Wyngaert
Alexis Genthon
Mara Memoli
Ollivier Legrand
Agnes Bonnin
Tounes Ledraa
Ramdane Belhocine
Simona Sestili
Jean El-Cheikh
Mohamad Mohty
Eolia Brissot
Bone Marrow Transplantation, 2023, 58 : 61 - 67
[7] Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation
Banet, Anne
Bazarbachi, Ali
Labopin, Myriam
Stocker, Nicolas
Dulery, Remy
Malard, Florent
Van de Wyngaert, Zoe
Genthon, Alexis
Memoli, Mara
Legrand, Ollivier
Bonnin, Agnes
Ledraa, Tounes
Belhocine, Ramdane
Sestili, Simona
El-Cheikh, Jean
Mohty, Mohamad
Brissot, Eolia
BONE MARROW TRANSPLANTATION, 2023, 58 (01) : 61 - 67
[8] Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on behalf of GETH-TC
Pena, M.
Martinez, D. F.
Paviglianiti, A.
Balaguer, A.
Sanz, J.
Pascual, M. J.
Herruzo, B.
Solano, C.
Benzaquen, A.
Salas, M. Q.
Rovira, M.
Nieto, A.
Espanol, I.
Huguet, M.
Bento, L.
Saez, A. J.
Mussetti, A.
BONE MARROW TRANSPLANTATION, 2025,
[9] Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT
Giorgia Battipaglia
Katya Mauff
Lotus Wendel
Emanuele Angelucci
Mohamad Mohty
William Arcese
Stella Santarone
Marie Therese Rubio
Nicolaus Kroger
Maria Laura Fox
Didier Blaise
Anna Paola Iori
Renato Fanin
Yves Chalandon
Pietro Pioltelli
Giuseppe Marotta
Patrizia Chiusolo
Matjaz Sever
Carlos Solano
Nathalie Contentin
Liesbeth C. de Wreede
Tomasz Czerw
Juan Carlos Hernandez-Boluda
Patrick Hayden
Donal McLornan
Ibrahim Yakoub-Agha
Bone Marrow Transplantation, 2021, 56 : 1593 - 1602
[10] Thiotepa, Busulfan and Fludarabine Conditioning Regimen in Adult Patients Undergoing Allogeneic Stem Cell Transplantation for Lymphoid Malignancies. a Study on Behalf of Geth-TC
Pena, Marta
Paviglianiti, Annalisa
Jesus Pascual, Maria
Herruzo, Beatriz
Solano, Carlos
Benzaquen, Ana
Queralt Salas, Maria
Rovira, Montserrat
Agustin Nieto
Espanol, Ignacio
Marin, Adolfo Jesus Saez
Bento De Miguel, Leyre
Sureda Balari, Anna Maria
Mussetti, Alberto
BLOOD, 2023, 142

← 1 2 3 4 5 →